Strategic Funding Tilak Healthcare recently secured a significant funding round of $10.6 million led by reputable investors. This injection of capital signifies growth opportunities and an increased focus on expanding market presence and developing new medical solutions.

Industry Recognition The partnership between Tilak Healthcare and renowned companies like Odysight.ai Inc and Elaia demonstrates industry acknowledgment and paves the way for collaboration opportunities, potentially leveraging the credibility of these established players.

Key Personnel Addition The appointment of Dr. Bénigne Mathieu as Chief Business Officer indicates a strategic move towards strengthening business operations and potentially opening up avenues for partnerships and new market engagements under experienced leadership.

Technological Integration Tilak Healthcare's collaboration with Voluntis Group to integrate OdySight ® Care™ with the Theraxium platform showcases a commitment to technological advancements. This integration could lead to cross-selling opportunities and enhanced product offerings.

Market Expansion With OdySight available in multiple languages and regions, including France, Spain, Belgium, and the US, Tilak Healthcare has already established a foothold in diverse markets. This opens up possibilities for further expansion and international sales growth.